Absence Seizures

• Thalamocortical circuit dysfunction: The thalamus serves as a relay station between cortex and periphery. Normally, this system maintains a sleep-wake cycle through controlled oscillations. In absence seizures, calcium channel abnormalities and altered GABAergic inhibition cause the thalamic reticular nucleus to hypersynchronize with relay neurons, creating a closed-loop circuit that generates synchronized burst firing. This pathologic oscillation at 3 Hz simultaneously engages bilateral cortical networks, producing the characteristic generalized spike-and-wave discharges on EEG. The synchronized thalamic output disrupts normal thalamocortical communication, interrupting consciousness and behavioral continuity while preventing motor manifestations typical of other generalized seizures.

• Calcium channel abnormalities: Multiple genetic variants affect voltage-gated calcium channels, particularly T-type calcium channels (particularly CACNA1H encoding Cav3.2) in thalamic neurons. These low-voltage-activated channels mediate burst firing in thalamic reticular neurons. Genetic mutations increase channel expression or alter gating kinetics, promoting abnormal burst firing patterns and predisposing to hypersynchronous oscillations. This explains the strong genetic basis of childhood absence epilepsy (CAE), with 50-60% familial clustering and twin concordance rates of 80-90%. The selective vulnerability of thalamic circuits explains why absence seizures are primarily generalized (bilateral and symmetric) rather than focal.

• GABAergic inhibitory imbalance: Enhanced GABAergic signaling paradoxically contributes to absence seizures by facilitating synchronized inhibition within thalamic reticular nucleus circuits. GABAergic interneurons in the reticular nucleus normally provide tonic inhibition to relay neurons; however, in absence epilepsy, these GABAergic synapses become hyperactive and hypersynchronized. This creates increased postinhibitory rebound firing—when synchronized inhibition ceases, relay neurons fire in synchronized bursts. Simultaneously, reduced GABA receptor expression in certain cortical regions may impair normal cortical inhibition, further promoting the generalized spike-and-wave pattern. Notably, this explains the paradoxical efficacy of ethosuximide, which specifically blocks T-type calcium channels without enhancing GABA, interrupting the pathologic burst-firing cycle.

• Cortical contribution and network involvement: While the thalamus initiates the 3 Hz oscillation, bilateral cortical networks amplify and sustain the spike-wave discharge. Cortical pyramidal neurons become hypersynchronized through excessive excitatory amino acid (glutamate) signaling and reduced cortical GABAergic tone. Neuroimaging studies demonstrate activation of bilateral frontal and parietal association cortices during absence seizures. The rostral intralaminar thalamic nuclei and anterior cingulate cortex appear particularly important in consciousness disruption. Disruption of thalamocortical connectivity fundamentally impairs the integration of information necessary for awareness and purposeful behavior, while the synchronous firing prevents motor manifestations by constraining motor output.

• Childhood Absence Epilepsy (CAE)—primary generalized epilepsy: CAE represents the most common form (60-70% of absence seizures) and is an idiopathic generalized epilepsy with strong genetic predisposition. Peak onset occurs between 4-8 years, with 90% of cases manifesting by age 12. Genetic inheritance follows complex polygenic patterns with variable penetrance; multiple susceptibility genes have been identified (CACNA1H, GABRG2, GABRA1, others). CAE shows female predominance (approximately 1.5:1) and often has a family history of epilepsy or febrile seizures. No structural brain abnormalities are present, and neuroimaging is typically normal.

• Juvenile Absence Epilepsy (JAE): This form accounts for 10-15% of absence seizures with later onset (ages 8-20 years), often accompanied by generalized tonic-clonic seizures (GTCS) in 60-80% of cases. JAE typically presents with fewer daily absence seizures (5-10 per day) compared to CAE, but the seizures are otherwise clinically similar. JAE also demonstrates genetic predisposition but with different genetic architecture than CAE. Prognosis is slightly less favorable than CAE, with lower rates of seizure freedom.

• Juvenile Myoclonic Epilepsy (JME)—overlap syndrome: JME is technically a distinct syndrome but may present with absence seizures (20-30% of JME patients), typically occurring in adolescents. JME combines myoclonic jerks (morning jerk), GTCS, and sometimes absence seizures. Photosensitivity is common (30-40% of cases). Unlike pure absence epilepsy, JME typically requires lifelong AED treatment.

• Secondary/provoked absences—rare but clinically important: Absence-like seizures can occur secondary to metabolic encephalopathy, liver failure, severe uremia, hypercalcemia, or non-convulsive status epilepticus (NCSE) in the ICU setting. These absence-like episodes lack the specific 3 Hz SWD pattern. Importantly, "absence seizures" associated with focal brain lesions or structural abnormalities should prompt evaluation for other seizure types or syndromes.

• Genetic syndromes and variants: Several rare genetic disorders present with absence seizures as a feature, including Dravet syndrome (severe myoclonic epilepsy of infancy, SCN1A mutations), GABRG2-related epilepsy (benign familial neonatal-infantile seizures), and progressive myoclonic epilepsies. These are distinguished by additional clinical and genetic features and represent a small minority of absence seizure cases.

• Behavioral arrest and impaired consciousness (hallmark feature): The cardinal manifestation is sudden, abrupt cessation of ongoing activity with behavioral unresponsiveness lasting typically 5-20 seconds (range 3-30 seconds). During an absence seizure, the patient appears to "stare blankly" or "daydream" but the key distinguishing feature is complete unresponsiveness—the patient cannot be aroused by voice or tactile stimuli during the episode. The patient immediately resumes prior activity after the seizure ends with no postictal confusion or fatigue, which distinguishes absence from other seizure types. This complete lack of postictal state is critical diagnostically because partial seizures and GTCS typically include postictal phenomena. Patients are amnestic for the episode, with no awareness of lost time.

• Subtle motor manifestations: While absence seizures are classified as "generalized non-motor seizures," subtle automatisms may occur in up to 90% of absence events, often missed by observers. These include eye fluttering (most common, occurring in 40-60% of seizures), mild facial myoclonia, perioral myoclonia, or lip smacking. Some patients exhibit brief (1-2 second) myoclonic jerks of the eyelids, eyebrows, or upper extremities. Importantly, there is no tonic or clonic activity, no loss of muscle tone, and no falls—the patient remains upright and aware of posture during the seizure. Occasionally patients exhibit automatisms such as picking at clothes or mild hand movements, but these are typically more subtle than automatisms in complex focal seizures.

• Frequent multiple daily seizures: Absence seizures typically occur very frequently, with patients experiencing 5-100+ episodes per day in untreated CAE, often in clusters. This high frequency distinguishes absence seizures from other primary generalized epilepsies where seizures may be more sporadic. Teachers often report that children "space out" multiple times during the school day, and parents describe dozens of brief pauses during play or meals. The cumulative cognitive burden of such frequent paroxysmal events contributes to potential academic and developmental consequences.

• Absence status epilepticus: Sustained absence seizures lasting minutes to hours represent absence status epilepticus, characterized by fluctuating impaired consciousness and persistent 3 Hz SWD on EEG. This occurs in 5-10% of absence epilepsy patients and may present acutely in undiagnosed patients or during medication adjustments. Clinically, patients appear confused, drowsy, or agitated with subtle facial/ocular automatisms. Unlike convulsive status epilepticus, there are no convulsions, but the condition is still a medical emergency requiring urgent AED administration.

• Physical examination findings: Interictal neurological examination is entirely normal in childhood absence epilepsy—this is a defining feature. There should be no focal neurological signs, no cognitive impairment on casual mental status testing (though formal neuropsychological testing may reveal subtle deficits), and normal gait/coordination. The absence of abnormal neurological signs helps confirm primary generalized epilepsy and argues against structural lesions. During a witnessed absence seizure, the examiner observes behavioral arrest and unresponsiveness; EEG captured during the episode shows the characteristic 3 Hz SWD.

• Clinical variants and associated features: In Juvenile Absence Epilepsy, absence seizures are often accompanied by generalized tonic-clonic seizures (GTCS), particularly upon awakening. In Juvenile Myoclonic Epilepsy, absences coexist with myoclonic jerks (morning jerks of arms) and GTCS. Some patients report brief warning symptoms before an absence (irritability, mood change) rather than true auras (which are typical of focal seizures). Importantly, a small subset of patients with absence seizures exhibit photosensitivity (seizures triggered by flickering lights), which occurs more commonly in JAE and JME than in CAE (though CAE photosensitivity is rare at 3-5%).

• Clinical history and semiology: The diagnosis begins with careful history from parents/teachers describing episodes: sudden behavioral arrest with behavioral unresponsiveness lasting seconds, no postictal confusion, multiple episodes daily, and onset in a child aged 4-12 years. Key historical elements include: (1) precipitants—seizures often occur with inattention or reduced consciousness during quiet activity, sometimes triggered by hyperventilation; (2) prior developmental normalcy and normal interictal function; (3) family history of epilepsy or febrile seizures; (4) absence of prior seizures or serious head injury. A critical part of the history is distinguishing absence seizures from ADHD or behavioral daydreaming—in ADHD, the child can be aroused by external stimuli during inattentive episodes, whereas in absence seizures, the patient is completely unresponsive. Obtaining detailed eyewitness accounts from teachers or video recordings of episodes significantly enhances diagnostic accuracy.

• Electroencephalography (EEG)—gold standard diagnostic test: EEG is the definitive diagnostic test for absence seizures and is mandatory for diagnosis. The characteristic finding is generalized 3 Hz spike-and-wave discharge (3 Hz SWD) on a normal background, occurring synchronously across all brain regions (bilateral, symmetric, and synchronous). The 3 Hz frequency is remarkably consistent across individual patients but may vary from 2.5-4 Hz in some cases. The spike component typically appears as a sharp deflection (lasting <80 milliseconds) followed by a slower wave. Between seizures (interictal EEG), many patients show the 3 Hz SWD pattern even during wakefulness, which supports the diagnosis. Ictal EEG (recorded during an actual seizure) shows continuous 3 Hz SWD with abrupt behavioral arrest concurrent with EEG change. Importantly, hyperventilation is a powerful precipitant of absence seizures during EEG—having the patient hyperventilate for 3-5 minutes reliably triggers seizures and SWD in 90% of patients with untreated CAE, making this a practical diagnostic maneuver. The sensitivity of EEG hyperventilation in triggering absence seizures exceeds 90% in untreated patients. Video-EEG telemetry simultaneously captures the clinical behavioral arrest with the ictal 3 Hz SWD, providing definitive correlation.

• Brain MRI and neuroimaging: MRI is normal in primary absence epilepsy and is not required for diagnosis if clinical presentation and EEG are typical. MRI should be obtained if: (1) age of seizure onset is atypical (<4 years or >12 years), (2) abnormal interictal neurological findings on exam, (3) EEG shows focal abnormalities rather than pure generalized 3 Hz SWD, or (4) seizures are refractory to first-line AEDs. MRI excludes secondary causes such as cortical malformations, mesial temporal sclerosis, or structural lesions that might cause seizures mimicking absence epilepsy.

• Laboratory studies: Routine laboratory testing (CBC, comprehensive metabolic panel, liver function tests) is typically normal in absence epilepsy and is not required for diagnosis. Labs are indicated if considering secondary causes (metabolic encephalopathy, liver disease, etc.). In some centers, genetic testing for CACNA1H and other susceptibility genes may be offered for research purposes but is not routinely necessary for clinical diagnosis or management.

• Differential diagnosis considerations:
• Complex focal seizures (CFS) with temporal lobe origin: These may present with behavioral arrest and unresponsiveness but typically last 20-60 seconds (longer than typical absence), have postictal confusion, show focal EEG abnormalities on EEG (often anterior temporal or unilateral), and may have aura preceding the event. In contrast, absence seizures are brief (5-20 seconds), have no postictal state, show generalized 3 Hz SWD, and lack aura.
• Attention-deficit/hyperactivity disorder (ADHD): The most common misdiagnosis. Unlike ADHD inattention, absence seizures involve complete unresponsiveness for seconds with abrupt offset. In ADHD, the child can be aroused by stimuli ("daydreaming but still somewhat responsive"). EEG with hyperventilation definitively differentiates the two.
• Non-convulsive status epilepticus (NCSE): Absence status can appear as altered consciousness with automatisms but typically lasts much longer (minutes to hours) and occurs in different clinical contexts (acute brain injury, medication withdrawal, infections). EEG shows continuous or near-continuous 3 Hz SWD rather than brief paroxysmal discharges.
• Focal seizures with impaired awareness: Frontal lobe seizures may present with brief behavioral arrest and subtle automatisms; however, EEG shows focal rather than generalized discharges, seizures are typically longer, and postictal confusion may occur.

• Diagnostic criteria: The International League Against Epilepsy (ILAE) Classification of seizure types and syndromes defines absence seizures within the generalized onset category. CAE is diagnosed by: (1) seizure onset between 4-12 years, (2) multiple daily brief seizures of behavioral arrest, (3) generalized 3 Hz SWD on EEG, (4) normal neurological exam and neuroimaging, (5) good response to ethosuximide. JAE requires similar criteria but with later onset (8-20 years) and frequent GTCS.

First-line pharmacological therapy

• Ethosuximide: This is the gold-standard first-line agent specifically for absence seizures (CAE and JAE), achieving seizure control in 60-70% of patients as monotherapy. Ethosuximide uniquely blocks low-voltage-activated T-type calcium channels in thalamic neurons, directly interrupting the pathologic burst-firing underlying absence seizure generation. The drug does not enhance GABA (unlike most other AEDs) and has minimal cognitive side effects. Dosing: start 10-15 mg/kg/day divided into 2-3 doses; titrate every 4-7 days by 5-10 mg/kg/day

Disease-related complications

• Absence status epilepticus: prolonged, self-sustaining thalamocortical spike-wave activity produces hours of fluctuating confusion, slowed responses, and subtle eyelid or perioral automatisms without convulsion. This is an emergency — an urgent EEG showing continuous or near-continuous generalized spike-and-wave confirms it, and an IV benzodiazepine (lorazepam) is the standard first step, mirroring the AES status epilepticus treatment algorithm. It is often precipitated by abrupt antiseizure drug withdrawal or by an inappropriate sodium-channel agent.
• Academic underachievement and psychiatric comorbidity: hundreds of daily lapses fragment attention and encoding, so children present with falling grades, teacher reports of "spacing out," and rates of ADHD, anxiety, and learning disability above the general pediatric population. The signal is a persisting attention problem after seizure freedom, which warrants neuropsychological testing rather than dose escalation.
• Injury and evolution to generalized tonic-clonic seizures: absences cause no fall, but a lapse while swimming, cycling, or (in adolescents) driving is dangerous; state driving-restriction rules apply. Up to a substantial minority — highest in juvenile absence epilepsy — develop GTCS, signaled by a first convulsion, often on awakening.

Treatment-related complications

• Ethosuximide: GI upset, hiccups, headache, and behavioral change are common; rare blood dyscrasias (agranulocytosis, aplastic anemia) and drug-induced lupus or Stevens-Johnson syndrome are the emergencies — fever, sore throat, or mucosal rash mandates immediate CBC and drug cessation.
• Valproate: mitochondrial beta-oxidation inhibition and carnitine depletion cause hepatotoxicity, pancreatitis, and hyperammonemic encephalopathy (rising lethargy with normal drug level — emergency); also thrombocytopenia, weight gain, tremor, alopecia, and PCOS. It is a potent teratogen (neural tube defects, reduced childhood IQ); FDA labeling and ACOG counseling make it a poor choice in girls of childbearing potential.
• Lamotrigine: Stevens-Johnson syndrome/TEN with rapid titration, and valproate inhibits its glucuronidation — doubling levels and requiring halved, slower titration. Any spreading rash with mucosal involvement is an emergency.
• Seizure aggravation: carbamazepine, oxcarbazepine, phenytoin, gabapentin, tiagabine, and vigabatrin can worsen absences or precipitate absence status.

• The buzzword pair: 3 Hz generalized spike-and-wave on a normal background plus behavioral arrest with no postictal confusion. If the stem gives postictal confusion, an aura, or an episode lasting more than about half a minute, the answer is a focal seizure with impaired awareness, not absence.
• Single best next step in a staring child: EEG with hyperventilation provocation — three to five minutes of hyperventilation induces hypocapnic cerebral vasoconstriction and reliably triggers a seizure in most untreated patients, making it the cheapest confirmatory maneuver at the bedside. MRI is not the next step in a neurologically normal 4-8 year old with typical semiology.
• The mechanism examiners test: T-type calcium channels in thalamic neurons drive the burst firing; ethosuximide blocks them. This is the reason ethosuximide works in absence but not in focal or tonic-clonic seizures.
• First-line drug and the caveat: Ethosuximide is first line for pure childhood absence epilepsy — the NIH-funded childhood absence epilepsy comparative trial found ethosuximide and valproate superior to lamotrigine, with ethosuximide causing fewer attentional adverse effects than valproate. But ethosuximide does not protect against GTCS: if the patient also has convulsions (juvenile absence epilepsy, juvenile myoclonic epilepsy), choose valproate — or levetiracetam/lamotrigine in a female of childbearing potential, given FDA and ACOG warnings on valproate teratogenicity.
• The classic drug trap: carbamazepine, oxcarbazepine, phenytoin, gabapentin, tiagabine, and vigabatrin worsen absence seizures and can precipitate absence status. A stem describing a "staring child started on carbamazepine who now stares more" is testing this.
• The distractor to avoid: ADHD. The discriminator is arousability — the inattentive child responds to a touch or a name; the child in an absence seizure cannot be aroused and is amnestic for the lapse.
• Prognosis: most children with childhood absence epilepsy remit by adolescence, so drug withdrawal after a sustained seizure-free interval is reasonable; juvenile myoclonic epilepsy, by contrast, usually needs lifelong therapy.